F-18-FDG PET/CT Findings in a Breast Cancer Patient with Concomitant Tuberculous Axillary Lymphadenitis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Jeong Won | - |
dc.contributor.author | Lee, Sang Mi | - |
dc.contributor.author | Choi, Jae Hyuck | - |
dc.date.accessioned | 2021-08-12T05:27:41Z | - |
dc.date.available | 2021-08-12T05:27:41Z | - |
dc.date.issued | 2011-06 | - |
dc.identifier.issn | 1869-3474 | - |
dc.identifier.issn | 1869-3482 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/16512 | - |
dc.description.abstract | Although F-18-fluorodeoxyglucose (F-18-FDG) positron emission tomography (PET) is a sensitive modality for detecting a malignant lesion, increased F-18-FDG uptake is also seen in infected or inflammatory processes. Here, we report the case of a breast cancer patient with concomitant tuberculous axillary lymphadenitis that showed increased F-18-FDG uptake. A 39-year-old woman underwent preoperative F-18-FDG PET/computed tomography (CT) as a part of the work-up for right breast cancer. F-18-FDG PET/CT images showed a malignant lesion in the right breast with moderate F-18-FDG uptake, and multiple enlarged right axillary lymph nodes with intense F-18-FDG uptake. Subsequently, the patient underwent right mastectomy and right axillary lymph node dissection. Histopathological examination confirmed breast cancer and tuberculous lymphadenitis, and the patient was treated concomitantly with anti-tuberculous therapy. | - |
dc.format.extent | 4 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한핵의학회 | - |
dc.title | F-18-FDG PET/CT Findings in a Breast Cancer Patient with Concomitant Tuberculous Axillary Lymphadenitis | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.1007/s13139-011-0080-1 | - |
dc.identifier.scopusid | 2-s2.0-79960045897 | - |
dc.identifier.wosid | 000217888800011 | - |
dc.identifier.bibliographicCitation | Nuclear Medicine and Molecular Imaging, v.45, no.2, pp 152 - 155 | - |
dc.citation.title | Nuclear Medicine and Molecular Imaging | - |
dc.citation.volume | 45 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 152 | - |
dc.citation.endPage | 155 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001558388 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.relation.journalWebOfScienceCategory | Radiology, Nuclear Medicine & Medical Imaging | - |
dc.subject.keywordAuthor | Breast cancer | - |
dc.subject.keywordAuthor | Tuberculosis | - |
dc.subject.keywordAuthor | F-18 fluorodeoxyglucose | - |
dc.subject.keywordAuthor | Positron emission tomography | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.